Skip to main content

Table 2 Key studies evaluating the LFD in IBS

From: Diet and irritable bowel syndrome: an update from a UK consensus meeting

Lead author

Year

Study design

Study duration

Total number of participants

Outcome

Short term

 Staudacher [45]

2012

RCT

4 weeks

41 IBS patients (Rome III)

68% response to LFD vs 23% on habitual diet (p = 0.005)

 Pedersen [46]

2014

RCT

6 weeks

123 IBS patients (Rome III)

Significant reduction in IBS-SSS on LFD compared to normal Danish/Western diet (133 vs 68, p < 0.01)

 Halmos [47]

2014

RCT

3 weeks

30 IBS patients (Rome III)

Lower overall gastrointestinal symptom scores on a LFD compared to Australian diet (23 vs 45, p < 0.001)

 Bohn [48]

2015

RCT

4 weeks

75 IBS patients (Rome III)

50% clinical response to LFD

 Eswaran [49]

2016

RCT

4 weeks

92 IBS-D patients (Rome III)

52% reported adequate relief of symptoms

 Zahedi [50]

2017

RCT

6 weeks

110 IBS-D patients (Rome III)

Significant reduction in IBS-SSS following LFD (264 vs 108, p < 0.001)

 Patcharatrakul [51]

2019

RCT

4 weeks

70 IBS patients (Rome III)

Global IBS symptom severity score using VAS were significantly lower following LFD compared to commonly recommended diet (39 vs 54, p < 0.01)

 Goyal [52]

2021

RCT

16 weeks

101 IBS-D patients (Rome IV)

63% response to LFD at week 4 and 53% response at week 16

Long term

 de Roest [53]

2013

Observational

16 months

90 IBS patients (Definition not stated)

Most symptoms including abdominal pain, bloating, flatulence and diarrhoea improved following LFD (p < 0.001)

 Peters [54]

2016

RCT

6 months

74 IBS patients (Rome III)

82% improvement noted following LFD relative to baseline symptoms at 6 months

 O’Keeffe [55]

2017

Prospective

6-18 months

74 IBS patients (Rome III)

57% reported satisfactory relief at long term following LFD

 Weynants [56]

2020

Retrospective

100 weeks

90 IBS patients (Rome III)

Patients following the LFD reported less abdominal pain than those who had stopped following the diet (p = 0.044)

 Bellini [57]

2020

Prospective

6-24 months

73 IBS patients (Rome IV)

Clinical response reported at 83% in those who continued LFD at long term

 Rej [58]

2021

Observational

44 months

205 IBS patients (Rome III)

60% reported satisfactory relief at long term following LFD

  1. Total number of studies (short term); n = 8, total number of participants; n = 642
  2. Total number of studies (long term); n = 6, total number of participants; n = 606